Hide Board Information

Show Board Information

CNS Pharmaceuticals Inc. CNSP

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/05/2024 2:52:26 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 32

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Stock Message Board

1. CNSP Company Profile

    

2. CNSP Time & Sales

    

3. CNSP Recent News

    

4. CNSP Filings

    

5. CNSP Financials

    

6. CNSP Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

300	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	07/05/2024 4:37:48 PM
299	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	06/26/2024 4:40:24 PM
298	$CNSP HOD 4 S3? THANKS for $	znewcar1	06/25/2024 2:53:59 PM
297	$CNSP HOD 4 S3? THANKS for $	znewcar1	06/25/2024 2:53:44 PM
296	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	06/17/2024 4:45:53 PM
295	CNSP f391,639 was all over! 06/14/2024 1:06:22 PM	znewcar1	06/14/2024 1:09:56 PM
294	$CNSP 30% v>8,2M @4.71 f391,639 Hod8.28 who else	znewcar1	06/14/2024 1:06:22 PM
293	Virginia Tech Clinical Trial Seeks End to Brain	NetworkNewsWire	06/03/2024 6:30:52 PM
292	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	06/03/2024 5:55:08 PM
291	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	05/20/2024 4:49:39 PM
290	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	05/16/2024 4:35:56 PM
289	New mRNA Vaccine Offers Hope Against Glioblastoma	NetworkNewsWire	05/15/2024 5:32:09 PM
288	Researchers Seek to Develop Genetically	NetworkNewsWire	04/26/2024 5:15:35 PM
287	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	04/23/2024 5:20:13 PM
286	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	04/22/2024 4:43:40 PM
285	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	04/15/2024 4:17:58 PM
284	Researchers Link Hormone Treatments to Heightened	NetworkNewsWire	04/08/2024 4:47:45 PM
283	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	04/02/2024 5:03:47 PM
282	New Research Sheds Light on the Initial Stages of	NetworkNewsWire	03/18/2024 5:13:54 PM
281	CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes	NetworkNewsWire	03/18/2024 4:58:37 PM
280	Study Shows Troops That Sustain Serious Brain	NetworkNewsWire	02/26/2024 4:52:57 PM
279	Scientists Start Trialing First Blood Test	NetworkNewsWire	02/05/2024 4:42:48 PM
278	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	01/30/2024 3:58:09 PM
277	Novel Brain Scan Technique Exposes Vulnerability	NetworkNewsWire	01/23/2024 4:41:23 PM
276	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	01/19/2024 4:02:12 PM
275	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	01/18/2024 3:07:41 PM
274	Multidisciplinary Consortium Sets Sights on	NetworkNewsWire	01/10/2024 4:40:50 PM
273	Light, Viruses Could Transform Brain-Tumor	NetworkNewsWire	12/28/2023 4:53:42 PM
272	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	12/18/2023 4:34:24 PM
271	Researchers Discuss How Brain Cancer Radiotherapy	NetworkNewsWire	12/15/2023 5:09:47 PM
270	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	12/06/2023 2:57:21 PM
269	Already-Approved Treatments Could Be Tested in	NetworkNewsWire	12/05/2023 5:07:12 PM
268	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/22/2023 3:40:57 PM
267	Study Finds DNA Loops in Brain Tumors in Kids	NetworkNewsWire	11/21/2023 5:11:39 PM
266	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/16/2023 3:40:24 PM
265	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	11/15/2023 4:09:16 PM
264	Brain Cancer Reemergence Could Soon Be Detected	NetworkNewsWire	11/09/2023 4:37:36 PM
263	Stanford Study Finds Lung Cancer Cells Hide,	NetworkNewsWire	10/27/2023 6:01:27 PM
262	Spanish Clinical Trial to Explore Marijuana as	NetworkNewsWire	10/24/2023 5:52:07 PM
261	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/20/2023 4:54:58 PM
260	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	10/19/2023 4:29:25 PM
259	Sonobiopsy Promises Easier Way to Diagnose Brain	NetworkNewsWire	10/18/2023 5:41:31 PM
258	NetworkNewsBreaks CNS Pharmaceuticals	NetworkNewsWire	10/16/2023 4:49:50 PM
257	Researchers Look for Novel Immunomodulating	NetworkNewsWire	10/12/2023 5:27:33 PM
256	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	10/11/2023 4:03:02 PM
255	First Time Ever: Researchers Eliminate Brain	NetworkNewsWire	10/06/2023 4:34:21 PM
254	Surgical Robot Prototype Could Ease Pediatric	NetworkNewsWire	09/26/2023 5:32:29 PM
253	Trial Enrollment Growth Supports Plans of CNS	NetworkNewsWire	09/25/2023 4:17:02 PM
252	Nottingham University Researchers Find Way to	NetworkNewsWire	09/20/2023 4:49:56 PM
251	NetworkNewsBreaks CNS Pharmaceuticals Inc.	NetworkNewsWire	09/15/2023 4:45:27 PM

Newer

Older

Recent Articles

• Celebrating Anna Lee Fisher: Pioneer Astronaut and Porsche Lover
• Evome Medical Technologies Unveils Key Outcomes from Shareholder Meeting
• Investigation Launched for Bumble Inc. Investors With Losses
• Where Food Comes From Insights: Q3 2024 Earnings Call Info
• VIVAZEN® Introduces a Fresh Alcohol Alternative™ Seltzer
• Top Recognition for Gair, Gair, Conason & Partners in 2025
• Pulmatrix Reports Q3 2024 Results: iSPERSE™ Developments and More
• Exploring AI's Future: The Role of Blockchain and Reinforcement Learning
• Yiwugo's Merchandise Sales Surge Ahead of Upcoming Festivals
• Industrial Granulated Sugar Market Forecast Exceeds $50 Billion
• Faruqi & Faruqi Launches Investigation into Acadia Healthcare
• Flight Data Monitoring Set to Transform Aviation Safety by 2030
• Physiotherapy Equipment Market Expected to Surge by 2029
• Timken Company Increases Quarterly Dividend to 34 Cents
• Investors Can Take Charge in Acadia Healthcare Fraud Case
• New Clinic by Family Care Center Enhances Mental Health Access
• Understanding Riksbank Auctions for Government Bonds
• Successful Sale of Former School Highlights Hilco's Expertise
• Investors Urged to Take Action Amid Evolv Technologies Scrutiny
• Exploring the Growing Image Sensor Market by 2029
• Exploring the Potential of Cloud Databases for the Future
• MEDFAR Celebrates 47th Spot in Canada’s Fastest-Growing Firms
• Medicenna Showcases Innovative Immunotherapy Developments
• Brookfield Property Partners Announces New Preferred Unit Dividends
• Revolutionary Biomarker Insights on CTX-471 at SITC Meeting
• Investors Urged to Act: Legal Options for UPS Shareholders
• FirstEnergy Welcomes New Leaders: Sagot & Davies Step Up
• Steel Dynamics Schedules Q4 2024 Cash Dividend Announcement
• Pathward Financial Sells Commercial Insurance Finance Unit
• Toei Animation Unveils Hypergalactic Game Universe with Twin Atlas
• Anesthesia Monitoring Devices Market Surges to $32.05 Billion Growth
• Kourtney Kardashian Barker Introduces Revolutionary Hair Supplement
• Investors Urged to Act as New Fortress Energy Faces Scrutiny
• Duke Energy Launches Initiative to Combat Hunger in Communities
• Exploring the Future of the Logistics Automation Sector
• Trading Halt Resolution Update from CleanSpark: Key Insights
• EPAM and IMF Unveil StatGPT 2.0 for Enhanced Economic Insights
• Victory for Demand The Limits: $2.5M Award in Injury Case
• Elanco Animal Health Investor Concerns and Legal Rights Explained
• Future of Air Quality Monitoring: Market Growth Insights
• Microfluidics Market Poised for Growth with AI and Diagnostics
• Future of Non-Volatile Memory: Analyzing Market Trends
• SP Group Launches Strategic Share Buy-Back Initiative
• CervoMed Celebrates Prix Galien USA Prize Recognition
• Cresud S.A.C.I.F. y A. Reports Q1 FY 2025 Financial Results
• Celebrating a Milestone: Shincheonji Church Graduation Event
• Faruqi & Faruqi Investigation into iLearningEngines Gains Insight
• ParkerVision Advocates for Patent Holder Rights in Supreme Court Case
• Critical Claims Investigation: Allarity Therapeutics Investor Alert
• Breakthrough Data on HBI-8000 and Nivolumab for Melanoma